黑牡丹(600510.SH):擬參與江蘇銀行配股事項
格隆匯 12 月 9日丨黑牡丹(600510.SH)公佈,截至公告披露日,公司持有江蘇銀行無限售條件流通股11000萬股,佔江蘇銀行總股本的0.95%。經測算,公司此次可認購配股數量上限為3300萬股,預計使用自有資金不超過人民幣15147萬元(公司最終認配數量及使用資金以實際成交為準)。董事會授權公司經營管理層根據江蘇銀行在配股發行前的市場情況等因素確定最終認配比例、認配數量和認配資金,並授權公司經營管理層根據市場情況擇機減持此次新增配售股份。
公司於2020年12月9日以通訊方式召開了八屆二十二次董事會會議,以9票同意、0票反對、0棄權審議通過了《關於參與江蘇銀行配股事項的議案》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.